Literature DB >> 25351905

Visceral adiposity index and insulin secretion and action in first-degree relatives of subjects with type 2 diabetes.

Yumei Yang1, Yan Feng, Xuesong Ma, Kaiting Chen, Nannan Wu, Dongmei Wang, Pengjie Li, Minnan Wang, Qiang Li, Jinchao Zhang.   

Abstract

BACKGROUND: To explore the predictive performance of the newly established visceral adiposity index for diabetes and prediabetes, as well as the relationships between the visceral adiposity index and the parameters of insulin secretion and action.
METHODS: Eight hundred twenty-four first-degree relatives of individuals with type 2 diabetes who had no known history of abnormal glucose regulation were selected. Diabetes and prediabetes were diagnosed using the standard oral glucose tolerance test.
RESULTS: The visceral adiposity index values were greater for the subjects with prediabetes and diabetes than for those with normal glucose regulation. Among the subjects with normal glucose regulation, the visceral adiposity index was higher for those whose levels were above the median value of the incremental area under the curve for glucose than for the subjects whose levels fell below the median value. The visceral adiposity index was negatively correlated with the homeostasis model assessment of the β-cell function index (Homa-β) and with the insulinogenic index (ΔI30 /ΔG30 ). The visceral adiposity index was found to be a valuable predictor of diabetes, but it was not superior to triglyceride levels, waist circumference, or lipid accumulation production.
CONCLUSIONS: The first degree relatives of people with type 2 DM who have prediabetes or diabetes have progressively higher visceral adiposity index in association with progressive hyperglycemia, and it was found to correlate with the Homa-β and the ΔI30 /ΔG30 .
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  first-degree relatives; insulin; resistance; type 2 diabetes; visceral adiposity index; β-cell function

Mesh:

Substances:

Year:  2015        PMID: 25351905     DOI: 10.1002/dmrr.2615

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  5 in total

1.  Association between visceral adiposity index and risk of prediabetes: A meta-analysis of observational studies.

Authors:  Dan Wang; Rui Fang; Haicheng Han; Jidong Zhang; Kaifei Chen; Xiaoqing Fu; Qinghu He; Yong Yang
Journal:  J Diabetes Investig       Date:  2021-10-21       Impact factor: 4.232

2.  Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study.

Authors:  Shuang Zheng; Sheng Shi; Xingxing Ren; Tingting Han; Yangxue Li; Yawen Chen; Wei Liu; Peter C Hou; Yaomin Hu
Journal:  J Transl Med       Date:  2016-09-07       Impact factor: 5.531

3.  Association of Visceral Adiposity Index, Lipid Profile, and Serum Leptin with Glucose Intolerance Risks in Iraqi Obese Patients: A Cross-sectional Study.

Authors:  Wael Waleed Mustafa; Samer Shukur Moahammed; Wathiq Mohammed Al-Jewari; Hussein Saad Abdulrahman; Saad Abdulrahman Hussain
Journal:  J Pharm Bioallied Sci       Date:  2020-10-08

4.  Visceral Adiposity Index and Chronic Kidney Disease in a Non-Diabetic Population: A Cross-Sectional Study.

Authors:  Hua Xiao; Chongxiang Xiong; Xiaofei Shao; Peichun Gao; Haishan Chen; Jing Ning; Yunying Chen; Ziliang Zou; Guobao Hong; Xiaolin Li; Xu You; Jieli Sheng; Fan Wu; Xin Wang; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-04       Impact factor: 3.168

5.  Using different anthropometric indices to assess prediction ability of type 2 diabetes in elderly population: a 5 year prospective study.

Authors:  Jing Yang; Fei Wang; Jing Wang; Xu Han; Hua Hu; Caizheng Yu; Jing Yuan; Ping Yao; Xiaoping Miao; Sheng Wei; Youjie Wang; Weihong Chen; Yuan Liang; Huan Guo; Xiaomin Zhang; Dan Zheng; Yuhan Tang; Handong Yang; Meian He
Journal:  BMC Geriatr       Date:  2018-09-17       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.